ReviewInfection and immunity2005

Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.

Thomas W Spahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.